&nbsp;

CART-cellTherapyAdultRelapsedRefractoryMantleCellLymphoma.pdf

Dec 2022

Statistical Reports

Indice de qualité du système de prévention : Rapport spécial sur la prévention du cancer chez les personnes atteintes de troubles mentaux graves

Document

ConstipationAndDiarrheaWebinarPresentation.pdf

Jan 2023

Document

ConstipationAndDiarrheaQA.pdf

Jan 2023

Regimen

CAPENERT

Cancer Type:

Breast

Intent: Palliative

Drugs Used:

neratinib (Unfunded),

capecitabine

Quick Link(s):

Regimen Monograph

Apr 2023

Regimen

CISPGEMC(W)

Cancer Type:

Gastrointestinal,

Pancreas

Intent: Palliative

Drugs Used:

CISplatin,

gemcitabine

Quick Link(s):

Regimen Monograph

Jan 2023

Regimen

CYCLDOCE+PEMB

Cancer Type:

Breast

Intent: Neoadjuvant

Funding:

New Drug Funding Program

Pembrolizumab - Previously Untreated High-Risk Early-Stage Triple Negative Breast Cancer

Drugs Used:

Quick Link(s):

Regimen Monograph

Sep 2023

Cervical Screening Letters

Colorectal Cancer Screening Letters

Regimen

CISPETOP+ATEZ

Cancer Type:

Lung,

Small Cell

Intent: Palliative

Funding:

New Drug Funding Program

Atezolizumab - In Combination with Etoposide and Platinum for Extensive-Stage Small Cell Lung Cancer

New Drug Funding Program

Atezolizumab - In Combination with Etoposide and Platinum for Extensive-Stage Small Cell Lung Cancer

Drugs Used:

atezolizumab,

atezolizumab (subcut),

CISplatin,

etoposide

Quick Link(s):

Regimen Monograph

May 2025

Regimen

CISPETOP(PO)+ATEZ

Cancer Type:

Lung,

Small Cell

Intent: Palliative

Funding:

ODB - General Benefit

etoposide - oral capsules

New Drug Funding Program

Atezolizumab - In Combination with Etoposide and Platinum for Extensive-Stage Small Cell Lung Cancer

New Drug Funding Program

Atezolizumab - In Combination with Etoposide and Platinum for Extensive-Stage Small Cell Lung Cancer

Drugs Used:

atezolizumab,

atezolizumab (subcut),

CISplatin,

etoposide

Quick Link(s):

Regimen Monograph

May 2025

Document